We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BAXTER HEALTHCARE SIGNS CONSENT DECREE FOR CGMP VIOLATIONS IN MAKING INFUSION PUMPS

BAXTER HEALTHCARE SIGNS CONSENT DECREE FOR CGMP VIOLATIONS IN MAKING INFUSION PUMPS

July 3, 2006

Baxter Healthcare has signed a consent decree with the FDA related to violations of current good manufacturing practices (cGMPs) in making two brands of infusion pumps, the agency said June 29.

Under the agreement approved by the U.S. District Court for the Northern District of Illinois, Baxter will stop manufacturing and distributing all models of its Colleague volumetric infusion pump and Syndeo patient controlled analgesic syringe pump in the U.S. until:It corrects manufacturing deficiencies; andThe devices are made in compliance with the FDA's cGMP requirements and quality systems regulation (QSR).

Infusion pumps are electronic devices used for intravenous and other forms of drug delivery. They provide medication in a continuous or intermittent manner for a prolonged period of time, the FDA said. "If they don't work properly, patients are put at risk," said Daniel Schultz, director of the FDA's Center for Devices and Radiological Health.

The FDA April 28 issued recommendations for healthcare providers and biomedical engineers to take additional safety steps beyond those issued by the manufacturer when using Baxter's Colleague pump.

The device "has exhibited a variety of problems, including under-infusion, battery failures, false alarms and failure to alarm," the agency said. ()a href="http://www.fdanews.com/ddl/33_27/" target=_blank>

KEYWORDS FDAnews Device Daily Bulletin

Upcoming Events

  • 08Sep

    Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

  • 15Sep

    Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

  • 20Sep

    Building a World-Class Pharmaceutical Advertising and Promotion Review Program

  • 21Sep

    The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

  • 22Sep

    FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

  • 11Oct

    1st Annual Quality Management vSummit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • AngioDynamics Gets Expanded Clearance for Auryon Atherectomy System

  • Aura Biosciences Receives Fast Track Designation for Bladder Cancer Candidate

  • FDA Issues Update on Becton Dickinson’s Recall

  • FDA Grants Accelerated Approval to Enhertu for HER2-Mutant NSCLC

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing